As Gash’s group has clearly demonstrated for GDNF injections in a non-human primate model of Parkinson’s disease, the amount of improvement motor performance measured by a clinical motor rating scale is directly related to the volume covered (Table 1). The gene discussed is GDNF; the disease is Parkinson disease.